Operating Margin - Giant Biogene Holding Co Ltd (HKEX:2367)

Watchlist Manager

Watchlist

Price: 34.66 HKD -4.25%

Market Cap: 37.1B HKD

42.8%

Current

45%

Average

5.1%

Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin

42.8%

Operating Profit

2.6B

Revenue

6.1B

Operating Margin Across Competitors

Country		Company	Market Cap	Operating Margin
CN	G	Giant Biogene Holding Co Ltd HKEX:2367	37.4B HKD	43%
FR		L'Oreal SA PAR:OR	197.6B EUR	20%
UK		Unilever PLC LSE:ULVR	118.2B GBP	18%
IN		Hindustan Unilever Ltd NSE:HINDUNILVR	5.4T INR	21%
UK		HALEON PLC LSE:HLN	32B GBP	23%
US		Estee Lauder Companies Inc NYSE:EL	38.7B USD	9%
DE		Beiersdorf AG XETRA:BEI	20.4B EUR	13%
JP		Kao Corp TSE:4452	2.9T JPY	10%
IN		Godrej Consumer Products Ltd NSE:GODREJCP	1.2T INR	18%
MY	B	Bioalpha Holdings Bhd KLSE:BIOHLDG	42.9B MYR	-124%
IN		Dabur India Ltd NSE:DABUR	890.7B INR	15%

Giant Biogene Holding Co Ltd
Glance View

Market Cap

37.1B HKD

Industry

Consumer products

In the bustling entrepreneurial landscape of China's Xi'an comes a formidable player in the skincare industry—Giant Biogene Holding Co Ltd. Founded in the early 2000s, the company quickly established itself as a pioneer in the biocosmetic field, underpinned by its commitment to leveraging cutting-edge biotechnologies. Positioned at the intersection of science and beauty, Giant Biogene concentrates on the research, production, and sale of bioactive skincare ingredients and products. These formulations, rich in proteins and polypeptides, target aspiring consumers eager to invest in beauty products that promise both efficacy and luxury. The company’s emphasis on integrating advanced bioengineering techniques with traditional Chinese medicinal practices has allowed it to carve out a distinct niche in the market, often emphasizing the scientific rigor and innovative spirit behind their product lines. Giant Biogene's revenue flows primarily from its comprehensive suite of skincare products, which are distributed through a variety of channels, including e-commerce platforms and retail partnerships. The company taps into the rising demand for premium anti-aging and skin-repair products in China's robust beauty market. This inclination towards advanced skincare solutions is largely fueled by an increasingly affluent middle class that places high value on personal care and appearance. The company further augments its revenue streams by developing proprietary formulas and licensing these innovative technologies to other skincare brands, thereby capitalizing on its formidable R&D capabilities. By maintaining a symbiotic relationship between its research endeavors and market strategy, Giant Biogene continues to thrive as a vanguard of scientific beauty solutions amid evolving consumer preferences.

View Giant Biogene Holding Co Ltd Analysis

Intrinsic Value

What is Intrinsic Value?

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term. Our analysis of the past 10 years showed that companies with a wide economic moat significantly outperformed the market, delivering +645% returns compared to +189% for the S&P 500.

Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.

The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.

Note: This research does not account for survivorship bias. Past performance is not indicative of future results.

Determining whether a company has an economic moat requires both a deep dive into financial metrics and a qualitative assessment of its competitive position. Our analysts conduct a rigorous evaluation that focuses on identifying structural advantages that enable a company to sustain profitability and defend its market share over the long term.

The process begins with an analysis of a company’s historical financial performance. We assess how consistently the company has generated returns above its cost of capital and whether those returns have been stable or improving. However, financial performance alone doesn’t reveal the full picture. To understand the sources of these advantages, we evaluate five key drivers of economic moats:

Network Effect: We analyze whether the value of a company’s product or service grows as its user base expands. Platforms like payment systems or marketplaces benefit from this self-reinforcing.

Switching Costs: We assess whether customers face significant costs or disruptions when switching to a competitor’s product or service. High switching costs create customer stickiness and provide pricing power.

Intangible Assets: Strong brands, patents, and regulatory licenses can protect a company’s market position by creating barriers for competitors or enabling premium pricing. For example, a well-recognized consumer brand may command higher customer loyalty and margins.

Efficient scale: Occurs when a market is optimally served by one or a few players, making it unprofitable for new entrants to compete. This typically happens in industries with high fixed costs or geographic constraints, such as utilities or pipelines.

Cost Advantage: Companies with structural cost advantages can produce goods or services at a lower cost than their competitors, enabling them to offer competitive pricing or maintain higher margins. These advantages often arise from economies of scale, superior supply chain management, or proprietary technology. Firms like Walmart leverage their massive scale to negotiate better terms with suppliers, allowing them to undercut competitors on price.

By examining these factors in combination with a company’s financial performance and market positioning, we classify each company into one of three categories:

This rigorous evaluation ensures that our moat ratings are both comprehensive and reliable, giving investors the tools they need to make well-informed, long-term decisions.

The AI Assistant may sometimes provide inaccurate information.

Make your own investment decisions or consult a licensed financial advisor.

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

O	Oesterreichische Post AG VSE:POST	30.6 EUR -1.13%
C	Cosco Capital Inc XPHS:COSCO	6.95 PHP
	Photocure ASA OSE:PHO	66.5 NOK 1.22%

	Johnson & Johnson NYSE:JNJ	206.54 USD 3.29%
	Berkshire Hathaway Inc NYSE:BRK.A	735 276 USD -0.14%
	Bank of America Corp NYSE:BAC	54.08 USD 1.01%
	Mastercard Inc NYSE:MA	538.86 USD 0.24%
	UnitedHealth Group Inc NYSE:UNH	328.37 USD 1.47%
	Exxon Mobil Corp NYSE:XOM	119.54 USD 1.09%

	Franklin Covey Co NYSE:FC	16.43 USD 1.67%
	Mohawk Industries Inc NYSE:MHK	111.7 USD 4.82%
	Ardmore Shipping Corp NYSE:ASC	11.41 USD -1.13%
	ASGN Inc NYSE:ASGN	46.48 USD 2.67%
	Skyworks Solutions Inc NASDAQ:SWKS	68.81 USD 0.39%
	Weatherford International PLC NASDAQ:WFRD	81.31 USD 1.51%

	Johnson & Johnson NYSE:JNJ	206.54 USD 3.29%
	Bank of America Corp NYSE:BAC	54.08 USD 1.01%
	Mastercard Inc NYSE:MA	538.86 USD 0.24%
	Salesforce Inc NYSE:CRM	264.2 USD 1.22%
	Abbvie Inc NYSE:ABBV	225.18 USD 0.98%
	Home Depot Inc NYSE:HD	351.13 USD 1.7%

Giant Biogene Holding Co Ltd
HKEX:2367